Fundraising FoxNeuroClear Technologies
Westport, US · Founded 2018 · Delaware corporation
Find your way into NeuroClear Technologies
Sign up to see every warm intro you have to NeuroClear Technologies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the NeuroClear Technologies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
SC
Steve ChaussyChief Financial Officer
KL
Kenneth LondonerChief Executive Officer and Director of the Issuer
ND
Natasha DrapeauDirector and Executive Vice President
JO
Jeffrey O'DonnellNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$14.9M disclosed across 4 rounds · 2019–2020
▶$10.8MraisedJun 2020 · 81 investors · Other Health CareRule 506(b)
▶$10.8MraisedJun 2020 · 81 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Dennis PurcellDirector
- Samuel NavarroDirector
- Anthony ZookDirector
- Nick SpringExecutive Officer, Director
- Steve ChaussyExecutive Officer
- Kenneth LondonerDirector
- Jeffrey O'DonnellDirector
- Michael DoughertyDirector
- Jerome ZeldisDirector
- Steven KingExecutive Officer
- Natasha DrapeauDirector
- Offering amount
- $25M
- Amount sold
- $10.8M
- Sales commissions
- $92K
- Placement agents
- Laidlaw & Company (UK) Ltd.
- First sale
- May 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$686.4KraisedNov 2019 · 8 investors · Other Health CareRule 506(b)
▶$686.4KraisedNov 2019 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Natasha DrapeauExecutive Officer, Director
- Kenneth LondonerExecutive Officer, Director
- Jeffrey O'DonnellDirector
- Steve ChaussyExecutive Officer
- Offering amount
- $20M
- Amount sold
- $686.4K
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$160KraisedSep 2019 · 1 investors · Other Health CareRule 506(b)
▶$160KraisedSep 2019 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Natasha DrapeauExecutive Officer, Director
- Kenneth LondonerExecutive Officer, Director
- Jeffrey O'DonnellDirector
- Steve ChaussyExecutive Officer
- Offering amount
- $160K
- Amount sold
- $160K
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$3.3MraisedAug 2019 · 17 investors · Other Health CareRule 506(b)
▶$3.3MraisedAug 2019 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steve ChaussyExecutive Officer
- Jeffrey O'DonnellDirector
- Kenneth LondonerExecutive Officer, Director
- Natasha DrapeauExecutive Officer, Director
- Offering amount
- $3.6M
- Amount sold
- $3.3M
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has NeuroClear Technologies raised?
- NeuroClear Technologies has disclosed $14.9M raised across 4 rounds.
- Where is NeuroClear Technologies headquartered?
- NeuroClear Technologies is headquartered in Westport, US.